Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286143 · ClinicalTrials.gov registry record · Phase 3
Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates
A Phase 3 study of Congenital Cystic Adenomatoid Malformation, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT00286143: Completed Phase 3 study of Congenital Cystic Adenomatoid Malformation, sponsored by Children's Hospital of Philadelphia.
NCT00286143 is a Phase 3 study of Congenital Cystic Adenomatoid Malformation that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 32 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286143, a Phase 3 study of Congenital Cystic Adenomatoid Malformation, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The study exams whether adding an opioid to the epidural infusion of a local anesthetic in neonates will significantly improve the quality of the postoperative analgesia.
Conditions Studied
Interventions
- DRUG Fentanyl
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
What the finished NCT00286143 record still lists
NCT00286143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Congenital Cystic Adenomatoid Malformation appearing as the primary indexed condition, and to 1 intervention - of which Fentanyl is the first listed.
NCT00286143 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00286143 about?
NCT00286143 is a clinical study titled "Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates". The study exams whether adding an opioid to the epidural infusion of a local anesthetic in neonates will significantly improve the quality of the postoperative analgesia.
What is the current status of trial NCT00286143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2005-02. Estimated completion is 2007-12.
What conditions does trial NCT00286143 study?
This clinical trial studies the following conditions: Congenital Cystic Adenomatoid Malformation.
What interventions are being tested in trial NCT00286143?
The interventions under investigation include: Fentanyl (DRUG).
Who is sponsoring clinical trial NCT00286143?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286143 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00286143's enrollment target sits among peer trials
32 1909th of 2000 higher than 87 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia